SFDA allowed the use of AstraZeneca COVID-19 vaccine that was devolved by the British company incorporation with Oxford University. SFDA’s decision is based on the scientific assessments and evaluation of the submitted documents.
For more Information
https://www.sfda.gov.sa/sites/default/files/2020-10/MDS-G21e.pdf
https://sfda.gov.sa/sites/default/files/2021-01/تعميم%20تحسين%20خدمات%20الهيئة-02.jpg
https://sfda.gov.sa/sites/default/files/2021-01/Guidance-MDMaintenanceEn.pdf
[et_pb_section admin_label=”section”] [et_pb_row admin_label=”row”] [et_pb_column type=”4_4″][et_pb_text admin_label=”Text”]
UDI Guidance: https://www.sfda.gov.sa/sites/default/files/2020- 09/MDS-G34e.pdf
UDI database (Saudi-DI): https://udi.sfda.gov.sa
For further enquiries regarding this announcement, please contact
md.rs@sfda.gov.sa or call 19999
[/et_pb_text][/et_pb_column] [/et_pb_row] [/et_pb_section]